Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-003612-30Phase 4Completed
Phase 4, randomised trial of heliox21 in respiratory failure and critical illness (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: CO2 production. Started Oct 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-003612-30.